• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• About NICE

• Who we are
  • Structure of NICE
  • Board
  • Senior Management Team
  • Guidance Executive
  • Partners Council
  • Policies and procedures
  • About the HDA
    • HDA publications
    • Evidence Base
    • NPHL Thesaurus
• What we do
• How we work
• NICE website development
• Jobs
• Tenders
• Scientific advice
• Commissioning Outcomes Framework
• Quality and Outcomes Framework
• NICE International
• NHS Evidence

Smoking and public health

The aim of this compendium is to identify a wide range of material that might contribute to the development, design, implementation and impact of future initiatives on smoking behaviour in a broad range of socially disadvantaged population groups.

Specifically, this compendium aims to:

• identify smoking behaviour initiatives that focus on socially disadvantaged populations
• incorporate evidence from as wide a range of published sources as possible (eg from randomised controlled trials [RCTs] through to qualitative studies and expert opinion pieces)
• highlight cost-effectiveness data, conflicting findings, gaps in the findings and provide a steer for commissioning further research to address these issues.

Smoking and public health 19 January 2007 (530.9Kb 03min 04sec @ 28.8Kbps)

Adobe Acrobat reader required.

This page was last updated: 03 August 2007